How to Adequately Treat Pseudomonas aeruginosa Infections

Abstract Pseudomonas aeruginosa is an opportunistic pathogen and a leading cause of hospital-acquired infections, particularly among immunocompromised patients, the critically ill, and those with indwelling devices or chronic lung disease such as cystic fibrosis. Its intrinsic resistance profile, capacity to acquire additional resistance to new antibiotics, and propensity to form protective biofilms make infections difficult to eradicate and prone to recurrence. With therapeutic options increasingly limited—often requiring last-line antibiotics—there is an urgent need for innovative strategies to counter growing resistance. This review provides a comprehensive overview of current approaches to the treatment of P. aeruginosa and highlights emerging therapies under active development.

Authors

Institutions

Publication Details

Journal
Seminars in Respiratory and Critical Care Medicine
Published
2026-11-12
DOI
https://doi.org/10.1055/a-2991-9004
Primary Topic
Bacterial biofilms and quorum sensing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

How to Adequately Treat Pseudomonas aeruginosa Infections

Daniel Reynolds, Marin H. Kollef, Alex S. Hartlage
Seminars in Respiratory and Critical Care Medicine
Bacterial biofilms and quorum sensing
article

How to Adequately Treat Pseudomonas aeruginosa Infections

Daniel Reynolds, Marin H. Kollef, Alex S. Hartlage
article en

Abstract

Abstract Pseudomonas aeruginosa is an opportunistic pathogen and a leading cause of hospital-acquired infections, particularly among immunocompromised patients, the critically ill, and those with indwelling devices or chronic lung disease such as cystic fibrosis. Its intrinsic resistance profile, capacity to acquire additional resistance to new antibiotics, and propensity to form protective biofilms make infections difficult to eradicate and prone to recurrence. With therapeutic options increasingly limited—often requiring last-line antibiotics—there is an urgent need for innovative strategies to counter growing resistance. This review provides a comprehensive overview of current approaches to the treatment of P. aeruginosa and highlights emerging therapies under active development.

Seminars in Respiratory and Critical Care Medicine
Washington University in St. Louis (US)
Good health and well-being
Bacterial biofilms and quorum sensing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon